1 Abdulmalak C, Cottenet J, Beltramo G, Georges M, Camus P, Bonniaud P, et al. Haemoptysis in adults: a 5-year study using the French nationwide hospital administrative database. Eur Respir J. 2015;46(2):503–11.
2 Stoffler D, Meyer FJ, Schwenger V. Das pulmorenale Syndrom auf der Intensivstation. Pneumologe. 2010;7:434–40.
3 Hellmark T, Segelmark M. Diagnosis and classification of Goodpasture’s disease (anti-GBM). Journal of Autoimmunity. 2014;(48–49):108–12.
4 Dammaco F, Battaglia S, Gesualdo L, Racanelli V. Goodpasture’s disease: A report of ten cases and a review of the literature. Autoimmunity Reviews. 2013;12:1101–8.
5 Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. J Clin Apher. 2016;31(3):149–62.
6 Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 2001;134:1033–42.
7 De Groot K, Harper L, Jayne DRW, Flores Suarez LF, Gregorini G, Gross WL. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis. Ann Intern Med. 2009;150:670–80.
8 Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W. European Vasculitis Study Group et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68:310–7.